A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors
Wei Zhang(Boehringer Ingelheim (Brazil)), Susanne Hipp(Technical University of Munich), Markus Fabits(Helmholtz Centre for Infection Research), Vladimir Voynov(Boehringer Ingelheim (Spain)), Anne B. Vogt, Paul J. Adam(Boehringer Ingelheim (Austria)), Ling Yang(Boehringer Ingelheim (Brazil)), Craig Giragossian(Boehringer Ingelheim (Spain)), Farzaneh Sayedian(HTG Molecular Diagnostics (United States)), Arnima Bisht(Oxford Biotherapeutics (United Kingdom)), Christian Walterskirchen(Boehringer Ingelheim (Austria)), Michael Bergmann(Comprehensive Cancer Center Vienna), M. Barnes(Oxford Biotherapeutics (United Kingdom)), Leticia Corrales(University of Chicago), Yu-Hsi Lin(Boehringer Ingelheim (Brazil)), Xiaoyun Liao(Bristol-Myers Squibb (Germany)), Aurélie Auguste(Veracyte (United States)), Lindsey Hudson(Oxford Biotherapeutics (United Kingdom)), Carina Binder(Medical University of Vienna), K. H. Bauer(Boehringer Ingelheim (Austria))
Cited by 20
Related Papers
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
|New England Journal of Medicine|2013|1.5k
Aspirin Use, Tumor<i>PIK3CA</i>Mutation, and Colorectal-Cancer Survival
|New England Journal of Medicine|2012|845
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
|JNCI Journal of the National Cancer Institute|2013|447
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
|Cancer Immunology Research|2015|440